Open access
Open access
Powered by Google Translator Translator

All Posts

Should Azithromycin be Used to Treat COVID-19?

20 May, 2020 | 09:47h | UTC

Should azithromycin be used to treat COVID-19? A rapid review – BJGP Open

 


Management of Acute Kidney Injury in Patients with COVID-19

19 May, 2020 | 04:40h | UTC

Management of acute kidney injury in patients with COVID-19 – The Lancet Respiratory Medicine

Related: Acute Kidney Injury In Patients Hospitalized With Covid-19 – Kidney International

 


Covid-19 Case Series: Acute Heart Failure in Multisystem Inflammatory Syndrome in Children

19 May, 2020 | 04:37h | UTC

Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic – Circulation

Related Case Report: Cardiac dysfunction and thrombocytopenia-associated multiple organ failure inflammation phenotype in a severe paediatric case of COVID-19 – The Lancet Child & Adolescent Health

 

Related Commentary on Twitter

 


Meta-Analysis: Psychiatric and Neuropsychiatric Presentations Associated with Severe Coronavirus Infections

19 May, 2020 | 04:39h | UTC

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic – The Lancet Psychiatry

 


Viewpoint: Accelerating COVID-19 Therapeutic Interventions and Vaccines

19 May, 2020 | 04:31h | UTC

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times – JAMA

Commentary: NIH Director: Defeating COVID-19 requires unprecedented action and collaboration – National Institutes of Health

Related Viewpoint: Planning for a COVID-19 Vaccination Program – JAMA

 


Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California

19 May, 2020 | 04:34h | UTC

Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020 – JAMA

“the prevalence of antibodies to SARS-CoV-2 was 4.65%. The estimate implies that approximately 367 000 adults had SARS-CoV-2 antibodies, which is substantially greater than the 8430 cumulative number of confirmed infections in the county on April 10”

 


Cross-neutralization of SARS-CoV-2 by a Human Monoclonal SARS-CoV Antibody

19 May, 2020 | 04:35h | UTC

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody – Nature

Commentary: Cross-neutralization of SARS and COVID-19 coronaviruses by a monoclonal antibody – News Medical

 


[No Publication Available] Hamster Research Shows Effectiveness of Masks ‘Huge’ in Covid-19 Battle

19 May, 2020 | 04:30h | UTC

Coronavirus: hamster research shows effectiveness of masks ‘huge’ in Covid-19 battle, Hong Kong scientists say – South China Morning Post

 


Decline in Child Vaccination Coverage During the COVID-19 Pandemic

19 May, 2020 | 04:26h | UTC

Decline in Child Vaccination Coverage During the COVID-19 Pandemic — Michigan Care Improvement Registry, May 2016–May 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: More evidence US childhood vaccinations are dropping amid coronavirus pandemic – CNN AND Michigan reports a sharp drop in child vaccinations after the CDC warned missed shots could lead to a measles resurgence across the US – Business Insider

 


SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany

19 May, 2020 | 04:22h | UTC

SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany – CDC Emerging Infectious Diseases

 


Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19

19 May, 2020 | 04:24h | UTC

Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19 – CDC Emerging Infectious Diseases

 


Early Data Show Moderna Covid-19 Vaccine Generates Immune Response

19 May, 2020 | 04:29h | UTC

Early data show Moderna Covid-19 vaccine generates immune response – STAT

See also: Moderna Coronavirus Vaccine Trial Shows Promising Early Results – The New York Times AND Expert reaction to Moderna announcement about their phase 1 trial data on their mRNA vaccine (mRNA-1273) candidate against COVID-19 – Science Media Centre

 


Infection of Dogs with SARS-CoV-2

19 May, 2020 | 04:19h | UTC

Infection of dogs with SARS-CoV-2 -Nature

Commentary: Coronavirus in cats and dogs: How does COVID-19 impact pets? – CNet

 


Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology

19 May, 2020 | 04:20h | UTC

Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology – American Journal of Respiratory and Critical Care Medicine

 


Cardiac Surgery during the COVID‐19 Pandemic

19 May, 2020 | 04:17h | UTC

Cardiac Surgery during the COVID‐19 Pandemic: Perioperative Considerations and Triage Recommendations – Journal of the American Heart Association

 


Resuming Elective Orthopedic Surgery During the COVID-19 Pandemic

19 May, 2020 | 04:15h | UTC

Resuming Elective Orthopaedic Surgery During the COVID-19 Pandemic: Guidelines Developed by the International Consensus Group (ICM) – Journal of Bone & Joint Surgery

 


COVID-19 Implications for Perioperative and Critical Care Physicians

19 May, 2020 | 04:18h | UTC

COVID-19 Infection: Implications for Perioperative and Critical Care Physicians – Anesthesiology

 


Open-access Science Funders Announce Price Transparency Rules for Publishers

19 May, 2020 | 04:12h | UTC

Open-access science funders announce price transparency rules for publishers – Science

Original Guidance: Plan S Price Transparency Frameworks: guidance & requirements – Plan S

News Release: cOAlition S announces price transparency requirements – Plan S

Related: Plan S: Making Full and Immediate Open Access a Reality AND UC Terminates Subscriptions with World’s Largest Scientific Publisher in Push for Open Access (several resources on the subject) AND PLOS and the University of California announce open access publishing agreement – PLOS Blogs AND The war to free science – Vox (free) AND WHO Joins Coalition for Free Digital Access to Health Research

 


Shifting the Paradigm: Using Disease Outbreaks to Build Resilient Health Systems

19 May, 2020 | 04:13h | UTC

Shifting the paradigm: using disease outbreaks to build resilient health systems – BMJ Global Health

 


Predicting Conversion to Wet Age-related Macular Degeneration Using Deep Learning

19 May, 2020 | 04:11h | UTC

Predicting conversion to wet age-related macular degeneration using deep learning – Nature Medicine (link to abstract – $ for full-text)

Commentary: Using AI to predict retinal disease progression – Deep Mind

 


New NICE Covid-19 Rapid Guidelines: Chronic Kidney Disease & Interstitial Lung Disease

18 May, 2020 | 02:15h | UTC

COVID-19 rapid guideline: chronic kidney disease – National Institute for Health and Care Excellence

COVID-19 rapid guideline: interstitial lung disease – National Institute for Health and Care Excellence

See also: Complete Collection of Covid-19 Rapid Guidelines

 


WHO Scientific Brief: Multisystem Inflammatory Syndrome in Children and Adolescents with COVID-19

18 May, 2020 | 02:18h | UTC

Multisystem inflammatory syndrome in children and adolescents with COVID-19 – World Health Organization

News Release: Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19

Related: Covid-19: Cases of inflammatory syndrome in children surge after urgent alert – The BMJ AND Description of an Outbreak of Severe Kawasaki-like Disease at the Italian Epicenter of the SARS-CoV-2 Epidemic

 


WHO Policy Brief: COVID-19 and the Need for Action on Mental Health

18 May, 2020 | 02:17h | UTC

Policy Brief: COVID-19 and the Need for Action on Mental Health – World Health Organization

News Release: Substantial investment needed to avert mental health crisis – World Health Organization

Commentary: “Mental health services are an essential part of all government responses to COVID-19” – United Nations

 


Randomized Trial: No Benefit from Hydroxychloroquine in Patients with Mild to Moderate Covid-19

18 May, 2020 | 02:11h | UTC

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial – The BMJ

Commentary: Further evidence does not support hydroxychloroquine for patients with COVID-19 – BMJ

 


Clinical Practice: Severe Covid-19

18 May, 2020 | 02:09h | UTC

Severe Covid-19 – New England Journal of Medicine

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.